Jamieson Wellness Inc.

TSX:JWEL Stock Report

Market Cap: CA$1.5b

Jamieson Wellness Valuation

Is JWEL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of JWEL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: JWEL (CA$35.25) is trading below our estimate of fair value (CA$90.12)

Significantly Below Fair Value: JWEL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for JWEL?

Key metric: As JWEL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for JWEL. This is calculated by dividing JWEL's market cap by their current earnings.
What is JWEL's PE Ratio?
PE Ratio37.2x
EarningsCA$39.51m
Market CapCA$1.47b

Price to Earnings Ratio vs Peers

How does JWEL's PE Ratio compare to its peers?

The above table shows the PE ratio for JWEL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.7x
LOVE Cannara Biotech
10xn/aCA$54.9m
A192820 Cosmax
20.4x27.3%₩1.5t
300791 Sirio Pharma
19.1x21.1%CN¥6.4b
4928 Noevir Holdings
21.4x2.5%JP¥170.4b
JWEL Jamieson Wellness
37.2x61.8%CA$1.5b

Price-To-Earnings vs Peers: JWEL is expensive based on its Price-To-Earnings Ratio (37.2x) compared to the peer average (17.7x).

Price to Earnings Ratio vs Industry

How does JWEL's PE Ratio compare vs other companies in the North American Personal Products Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
JWEL 37.2xIndustry Avg. 26.6xNo. of Companies4PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: JWEL is expensive based on its Price-To-Earnings Ratio (37.2x) compared to the North American Personal Products industry average (26.6x).

Price to Earnings Ratio vs Fair Ratio

What is JWEL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

JWEL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate JWEL's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst JWEL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCA$35.25
CA$40.04
+13.6%
5.0%CA$42.00CA$36.50n/a7
Nov ’25CA$32.92
CA$38.82
+17.9%
6.0%CA$42.00CA$36.25n/a7
Oct ’25CA$34.68
CA$38.72
+11.6%
5.6%CA$42.00CA$36.25n/a8
Sep ’25CA$31.12
CA$38.72
+24.4%
5.6%CA$42.00CA$36.25n/a8
Aug ’25CA$32.30
CA$36.19
+12.0%
8.3%CA$42.00CA$32.00n/a8
Jul ’25CA$29.01
CA$34.72
+19.7%
12.0%CA$42.00CA$27.00n/a9
Jun ’25CA$26.75
CA$34.72
+29.8%
12.0%CA$42.00CA$27.00n/a9
May ’25CA$26.09
CA$35.05
+34.3%
13.0%CA$42.00CA$28.00n/a10
Apr ’25CA$26.17
CA$35.33
+35.0%
13.3%CA$42.00CA$28.00n/a9
Mar ’25CA$30.67
CA$39.17
+27.7%
12.6%CA$46.00CA$32.00n/a9
Feb ’25CA$30.92
CA$38.61
+24.9%
15.2%CA$46.00CA$27.00n/a9
Jan ’25CA$31.73
CA$38.90
+22.6%
15.0%CA$46.00CA$27.00n/a10
Dec ’24CA$30.15
CA$38.90
+29.0%
15.0%CA$46.00CA$27.00n/a10
Nov ’24CA$23.05
CA$41.10
+78.3%
12.6%CA$50.00CA$32.00CA$32.9210
Oct ’24CA$24.37
CA$41.10
+68.6%
12.6%CA$50.00CA$32.00CA$34.6810
Sep ’24CA$25.85
CA$41.60
+60.9%
13.8%CA$50.00CA$32.00CA$31.1210
Aug ’24CA$30.74
CA$43.53
+41.6%
9.3%CA$50.00CA$37.00CA$32.3010
Jul ’24CA$30.01
CA$43.60
+45.3%
9.2%CA$50.00CA$37.00CA$29.0110
Jun ’24CA$30.53
CA$43.60
+42.8%
9.2%CA$50.00CA$37.00CA$26.7510
May ’24CA$33.34
CA$43.45
+30.3%
9.5%CA$50.00CA$37.00CA$26.0910
Apr ’24CA$33.49
CA$43.45
+29.7%
9.5%CA$50.00CA$37.00CA$26.1710
Mar ’24CA$32.37
CA$43.45
+34.2%
9.5%CA$50.00CA$37.00CA$30.6710
Feb ’24CA$37.11
CA$44.53
+20.0%
7.8%CA$50.00CA$39.00CA$30.9210
Jan ’24CA$35.09
CA$44.53
+26.9%
7.8%CA$50.00CA$39.00CA$31.7310
Dec ’23CA$33.13
CA$44.53
+34.4%
7.8%CA$50.00CA$39.00CA$30.1510
Nov ’23CA$34.29
CA$45.43
+32.5%
6.9%CA$50.00CA$39.00CA$23.0510

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Emergence Global Enterprises

CA$4.9m

Develops and distributes natural health foods, supplements, and sports nutrition specialty supplements in North America.

EMRG

CA$0.05

7D

0%

1Y

-77.8%